[go: up one dir, main page]

PL1807101T3 - Urządzenia i sposoby do zintegrowanego wytwarzania cząsteczek biologicznych w sposób ciągły - Google Patents

Urządzenia i sposoby do zintegrowanego wytwarzania cząsteczek biologicznych w sposób ciągły

Info

Publication number
PL1807101T3
PL1807101T3 PL05800224.7T PL05800224T PL1807101T3 PL 1807101 T3 PL1807101 T3 PL 1807101T3 PL 05800224 T PL05800224 T PL 05800224T PL 1807101 T3 PL1807101 T3 PL 1807101T3
Authority
PL
Poland
Prior art keywords
methods
devices
biological molecules
continuous manufacturing
integrated continuous
Prior art date
Application number
PL05800224.7T
Other languages
English (en)
Inventor
Jens Vogel
Roberto Giovannini
Konstantin B. Konstantinov
Huong Nguyen
Peng Wu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36143124&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1807101(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of PL1807101T3 publication Critical patent/PL1807101T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/06Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/145Ultrafiltration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/145Extraction; Separation; Purification by extraction or solubilisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00Apparatus for enzymology or microbiology
    • C12M1/24Apparatus for enzymology or microbiology tube or bottle type
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12Purification
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2311/00Details relating to membrane separation process operations and control
    • B01D2311/14Pressure control
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2311/00Details relating to membrane separation process operations and control
    • B01D2311/16Flow or flux control
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/10Specific supply elements
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/10Specific supply elements
    • B01D2313/105Supply manifolds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2313/00Details relating to membrane modules or apparatus
    • B01D2313/18Specific valves
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2317/00Membrane module arrangements within a plant or an apparatus
    • B01D2317/04Elements in parallel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Sustainable Development (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Filtration Of Liquid (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL05800224.7T 2004-09-30 2005-09-30 Urządzenia i sposoby do zintegrowanego wytwarzania cząsteczek biologicznych w sposób ciągły PL1807101T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61499504P 2004-09-30 2004-09-30

Publications (1)

Publication Number Publication Date
PL1807101T3 true PL1807101T3 (pl) 2016-11-30

Family

ID=36143124

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05800224.7T PL1807101T3 (pl) 2004-09-30 2005-09-30 Urządzenia i sposoby do zintegrowanego wytwarzania cząsteczek biologicznych w sposób ciągły

Country Status (24)

Country Link
US (3) US9045725B2 (pl)
EP (2) EP2550971B1 (pl)
JP (2) JP5579966B2 (pl)
KR (2) KR101335936B1 (pl)
CN (2) CN101076347B (pl)
AU (1) AU2005292358B2 (pl)
BR (1) BRPI0515849B1 (pl)
CA (1) CA2579845C (pl)
CY (1) CY1117699T1 (pl)
DK (2) DK2550971T3 (pl)
ES (2) ES2634323T3 (pl)
HR (1) HRP20070097B1 (pl)
HU (2) HUE027136T2 (pl)
IL (5) IL181775A (pl)
LT (1) LT2550971T (pl)
NO (2) NO341439B1 (pl)
NZ (2) NZ588616A (pl)
PL (1) PL1807101T3 (pl)
PT (1) PT2550971T (pl)
RU (1) RU2390526C2 (pl)
SI (1) SI2550971T1 (pl)
UA (3) UA112529C2 (pl)
WO (1) WO2006039588A2 (pl)
ZA (1) ZA200702578B (pl)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5579966B2 (ja) 2004-09-30 2014-08-27 バイヤー ヘルスケア エルエルシー 生体分子の一貫連続製造のための装置及び方法
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
CN103276033A (zh) 2006-09-13 2013-09-04 雅培制药有限公司 细胞培养改良
FR2920429B1 (fr) * 2007-08-30 2012-10-05 Lfb Biotechnologies Procede de purification du facteur viii et du facteur von willebrand
CN105111309A (zh) * 2008-10-20 2015-12-02 Abbvie公司 使用a蛋白亲和层析分离和纯化抗体
CN104974251A (zh) 2008-10-20 2015-10-14 Abbvie公司 在抗体纯化过程中的病毒灭活
US9527010B2 (en) 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
EP2627428A4 (en) * 2010-10-15 2016-08-31 Ge Healthcare Bio Sciences ONE-WAY ULTRA-FILTRATION SYSTEMS AND METHODS OF LARGE VOLUME
CN102154408B (zh) * 2011-01-13 2013-06-05 天津市工业微生物研究所 小核菌硬葡聚糖在线发酵提取方法及系统
US10774304B2 (en) * 2011-03-08 2020-09-15 University Of Maryland, Baltimore County System and method for production of on-demand proteins in a portable unit for point of care delivery
WO2012122413A1 (en) * 2011-03-08 2012-09-13 University Of Maryland Baltimore County Microscale bioprocessing system and method for protein manufacturing
US12227734B2 (en) 2011-03-08 2025-02-18 University Of Maryland, Baltimore County Microscale bioprocessing system and method for protein manufacturing from human blood
US9982227B2 (en) 2011-03-08 2018-05-29 University Of Maryland, Baltimore County System and method for production of on-demand proteins in a portable unit for point of care delivery
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
CA2852052C (en) * 2011-10-11 2017-01-17 Sentry Depressurization Systems, Inc. Depressurization system for an electrical transformer
CA2861270C (en) 2012-01-18 2021-08-03 Bayer Healthcare Llc Perfusion bioreactor systems comprising a cell aggregate trap and methods of operating the same
US9997264B2 (en) * 2012-02-14 2018-06-12 Control Components, Inc. Enhanced nuclear sump strainer system
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
AU2013309506A1 (en) 2012-09-02 2015-03-12 Abbvie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
EP2958988A2 (en) 2013-02-22 2015-12-30 Genzyme Corporation Microcarrier perfusion culturing methods and uses thereof
ES2717927T3 (es) 2013-02-22 2019-06-26 Genzyme Corp Procedimientos de cultivo por perfusión de microportadores y usos de los mismos
IL274646B (en) 2013-03-08 2022-09-01 Genzyme Corp Integrated continuous production of medicinal substances from medical protein
EP2830651A4 (en) 2013-03-12 2015-09-02 Abbvie Inc HUMAN ANTIBODIES THAT BIND TNF-ALPHA AND PREPARATION METHODS
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
US9499614B2 (en) 2013-03-14 2016-11-22 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
EP3052640A2 (en) 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
TWI709569B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析樹脂及其用於製造方法的用途
TWI709570B (zh) 2014-01-17 2020-11-11 美商健臻公司 無菌層析法及製法
WO2015166083A1 (en) * 2014-05-02 2015-11-05 Novo Nordisk A/S Integrated continuous biomanufacturing process
CN112588116A (zh) 2014-05-13 2021-04-02 美国安进公司 用于过滤器和过滤过程的过程控制系统和方法
EP3148713B1 (en) * 2014-05-27 2025-02-12 Artificial Cell Technologies, Inc. Automated layer by layer construction of multilayer coated cores by tff
TW202204596A (zh) 2014-06-06 2022-02-01 美商健臻公司 灌注培養方法及其用途
TWI776235B (zh) 2014-06-09 2022-09-01 美商健臻公司 種子罐培養法(seed train processes)及其用途
WO2015195453A2 (en) 2014-06-16 2015-12-23 Emd Millipore Corporation Methods for increasing the capacity of flow-through processes
WO2015195452A2 (en) 2014-06-16 2015-12-23 Emd Millipore Corporation Single-pass filtration systems and processes
KR101938948B1 (ko) 2014-06-25 2019-01-15 이엠디 밀리포어 코포레이션 밀집한 나권형 필터 엘리먼트, 모듈 및 시스템
WO2016033546A1 (en) 2014-08-29 2016-03-03 Emd Millipore Corporation Single pass tangential flow filtration systems and tangential flow filtration systems with recirculation of retentate
WO2016033553A1 (en) 2014-08-29 2016-03-03 Emd Millipore Corporation Processes for filtering liquids using single pass tangential flow filtration systems and tangential flow filtration systems with recirculation of retentate
USD762811S1 (en) 2014-12-18 2016-08-02 Emd Millipore Corporation Diverter plate
USD761381S1 (en) 2014-12-18 2016-07-12 Emd Millipore Corporation Retentate plate
EP3093335A1 (de) 2015-05-13 2016-11-16 Bayer Technology Services GmbH Prozessleitsystem zur regelung und steuerung einer modular aufgebauten anlage zur produktion von biopharmazeutischen und biologischen makromolekularen produkten
ITUA20161506A1 (it) * 2016-03-09 2017-09-09 Della Toffola Spa Metodo ed impianto perfezionato di filtrazione tangenziale
US20200289987A1 (en) 2016-03-14 2020-09-17 Pendotech Processing System for Multiple Tangential Flow Filtration Stations in Bioprocessing Applications
US12226737B2 (en) 2016-06-09 2025-02-18 Emd Millipore Corporation Radial-path filter elements, systems and methods of using same
SG10202108510UA (en) * 2016-07-21 2021-09-29 Agency Science Tech & Res Apparatus for outer wall focusing for high volume fraction particle microfiltration and method for manufacture thereof
KR20190079662A (ko) * 2016-11-11 2019-07-05 바이엘 악티엔게젤샤프트 연속적 유동 내의 오염물을 모니터링하기 위한 유체 스트림의 샘플링 방법
EP3141594A3 (en) * 2016-11-11 2017-06-14 Bayer Pharma Aktiengesellschaft Method for sampling fluid streams for monitoring contaminants in a continuous flow
WO2018107099A1 (en) * 2016-12-09 2018-06-14 Lonza Ltd Method for the reduction of viral titer in pharmaceuticals
EP3354330A1 (en) 2017-01-25 2018-08-01 Sartorius Stedim Biotech GmbH Automated modular filtration system
CA2994643A1 (en) * 2017-02-14 2018-08-14 Bart Lipkens Bioreactor using acoustic standing waves
JP6682172B2 (ja) * 2017-03-03 2020-04-15 富士フイルム株式会社 細胞培養装置及び細胞培養方法
JP2018153168A (ja) * 2017-03-21 2018-10-04 国立大学法人九州大学 微生物収集装置
DE102017110482A1 (de) * 2017-05-15 2018-11-15 Sartorius Stedim Biotech Gmbh Filtrationsmodul bzw. Reinigungsmodul für modulares Filtrationssystem
DE102017111133A1 (de) 2017-05-22 2018-11-22 Sartorius Stedim Biotech Gmbh Vorkonfigurierte Einweg-Filtrationsvorrichtung
TWI675696B (zh) * 2017-06-01 2019-11-01 美商Emd密理博公司 用於灌注應用之切向流過濾裝置
CN111093812B (zh) * 2017-06-20 2022-08-23 旭化成株式会社 中空纤维膜组件及过滤方法
TWI898645B (zh) 2018-05-04 2025-09-21 美商健臻公司 灌注式細胞培養裝置
US12071607B2 (en) * 2018-06-01 2024-08-27 Lonza Ltd. Midscale model for organic growth and phasing
GB201810772D0 (en) 2018-06-29 2018-08-15 Ge Healthcare Bio Sciences Ab Method in bioprocess purification system
EP3843869A1 (en) 2018-08-31 2021-07-07 Genzyme Corporation Sterile chromatography resin and use thereof in manufacturing processes
GB201816871D0 (en) * 2018-10-17 2018-11-28 Ge Healthcare Bio Sciences Ab A bioprocessing fluid sensor arrangement
DE102019100209A1 (de) 2019-01-07 2020-07-09 Sartorius Stedim Biotech Gmbh Vorrichtung und Verfahren zum Ausgleich von kurzfristigen Druck- oder Volumenschwankungen eines Mediums in einem kontinuierlich geführten biopharmazeutischen Prozess
US20220119757A1 (en) * 2019-02-15 2022-04-21 Just-Evotec Biologics, Inc. Automated biomanufacturing systems, facilities, and processes
CN111018968B (zh) * 2019-12-16 2021-07-27 兴盟生物医药(苏州)有限公司 一种通过超滤浓缩制备高浓度抗体制剂的方法
EP4036672B1 (en) 2021-01-29 2024-03-06 Tata Consultancy Services Limited Method to control a continuous bioprocessing
GB202109015D0 (en) * 2021-06-23 2021-08-04 Puridify Ltd A method for purifying a feed in a chromatography system
WO2023191009A1 (ja) * 2022-03-30 2023-10-05 富士フイルム株式会社 バイオ医薬品の原薬の製造方法、バイオ医薬品の原薬の製造システム、およびバイオ医薬品の原薬
WO2023191008A1 (ja) * 2022-03-30 2023-10-05 富士フイルム株式会社 バイオ医薬品の原薬の製造方法、バイオ医薬品の原薬の製造システム、およびバイオ医薬品の原薬
EP4594462A1 (en) * 2022-09-28 2025-08-06 Genzyme Corporation Systems and devices for producing biological products and methods of using the same

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5157113A (en) * 1987-08-10 1992-10-20 Miles Inc. Removal of nucleic acids from monoclonal antibody preparations
US5256294A (en) 1990-09-17 1993-10-26 Genentech, Inc. Tangential flow filtration process and apparatus
US5463029A (en) * 1992-11-23 1995-10-31 Immunex Corporation Purification of fusion proteins comprising GM-CSF and IL-3
EP0757717B1 (en) * 1994-05-16 2006-05-31 Merck & Co. Inc. Papillomavirus vaccines
US5616595A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Process for recovering water insoluble compounds from a fermentation broth
JP3566461B2 (ja) 1996-06-28 2004-09-15 ユニ・チャーム株式会社 使い捨ての体液吸収性物品
US7122344B2 (en) * 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
DE19837391A1 (de) * 1997-08-22 1999-02-25 Hoffmann La Roche Immunologische Materialien und Verfahren zum Nachweis von Dihydropyrimidindehydrogenase
US6022477A (en) * 1997-11-14 2000-02-08 New Jersey Institute Of Technology Method and apparatus for isolation purification of biomolecules
US7820796B2 (en) 1998-03-12 2010-10-26 Genetics Institute, Llc. Methods for producing Factor VIII proteins
US6444223B1 (en) * 1999-05-28 2002-09-03 Alkermes Controlled Therapeutics, Inc. Method of producing submicron particles of a labile agent and use thereof
US6544424B1 (en) * 1999-12-03 2003-04-08 Refined Technology Company Fluid filtration system
US6350382B1 (en) * 2000-06-23 2002-02-26 Scilog, Inc. Enhancing filtration yields in tangential flow filtration
EP1417475A4 (en) * 2001-07-06 2006-06-28 454 Corp METHOD FOR ISOLATING INDEPENDENT, PARALLEL CHEMICAL MICRORE ACTIONS USING A POROUS FILTER
ES2357423T3 (es) * 2001-08-31 2011-04-26 Bayer Schering Pharma Aktiengesellschaft Unidad y procedimiento para realizar fermentación a alta densidad celular.
US6875459B2 (en) * 2001-09-10 2005-04-05 Henry B. Kopf Method and apparatus for separation of milk, colostrum, and whey
US7078507B2 (en) * 2001-11-09 2006-07-18 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Synthetic genes for malarial proteins and methods of use
CA2457262A1 (fr) * 2003-02-11 2004-08-11 Centre National En Electrochimie Et En Technologies Environnementales In C. Procede et dispositif pour la production de biomolecules en continu
JP2006515227A (ja) * 2003-02-24 2006-05-25 ジーティーシー バイオセラピューティックス インコーポレイテッド 十字流濾過の方法およびそのための装置
US20050197496A1 (en) 2004-03-04 2005-09-08 Gtc Biotherapeutics, Inc. Methods of protein fractionation using high performance tangential flow filtration
JP5579966B2 (ja) 2004-09-30 2014-08-27 バイヤー ヘルスケア エルエルシー 生体分子の一貫連続製造のための装置及び方法

Also Published As

Publication number Publication date
ES2570006T3 (es) 2016-05-13
SI2550971T1 (sl) 2017-08-31
NZ554307A (en) 2011-06-30
KR101238798B1 (ko) 2013-03-04
HUE027136T2 (en) 2016-08-29
EP1807101A4 (en) 2010-03-24
RU2390526C2 (ru) 2010-05-27
CN102794109B (zh) 2015-10-07
CN101076347B (zh) 2012-09-26
UA107937C2 (en) 2015-03-10
IL205228A0 (en) 2011-07-31
PT2550971T (pt) 2017-10-02
UA99249C2 (ru) 2012-08-10
IL217158A0 (en) 2012-01-31
WO2006039588A3 (en) 2007-05-18
US20130344585A1 (en) 2013-12-26
IL217159A (en) 2015-04-30
NO20072174L (no) 2007-06-27
ZA200702578B (en) 2008-03-26
KR20130003025A (ko) 2013-01-08
IL181775A (en) 2012-02-29
HUE032538T2 (en) 2017-10-30
WO2006039588A2 (en) 2006-04-13
NZ588616A (en) 2012-05-25
BRPI0515849A (pt) 2008-08-12
AU2005292358A1 (en) 2006-04-13
NO341439B1 (no) 2017-11-13
EP1807101A2 (en) 2007-07-18
HK1110519A1 (en) 2008-07-18
NO20171138A1 (no) 2007-06-27
BRPI0515849B1 (pt) 2019-07-30
KR20070092949A (ko) 2007-09-14
IL205228A (en) 2015-09-24
CA2579845C (en) 2014-11-18
EP2550971B1 (en) 2016-11-09
CN101076347A (zh) 2007-11-21
CY1117699T1 (el) 2017-05-17
LT2550971T (lt) 2018-10-25
NO341885B1 (no) 2018-02-12
KR101335936B1 (ko) 2013-12-03
JP2008514237A (ja) 2008-05-08
HRP20070097B1 (hr) 2018-03-23
JP2012213772A (ja) 2012-11-08
IL181775A0 (en) 2007-07-04
DK1807101T3 (en) 2016-05-23
CA2579845A1 (en) 2006-04-13
RU2007115901A (ru) 2008-11-10
US20080269468A1 (en) 2008-10-30
IL217157A (en) 2015-04-30
DK2550971T3 (en) 2017-10-30
EP2550971A1 (en) 2013-01-30
CN102794109A (zh) 2012-11-28
US20130345402A1 (en) 2013-12-26
US9133433B2 (en) 2015-09-15
IL217158A (en) 2016-06-30
HRP20070097A2 (hr) 2008-11-30
JP5579966B2 (ja) 2014-08-27
JP5762360B2 (ja) 2015-08-12
IL217159A0 (en) 2012-01-31
IL217157A0 (en) 2012-01-31
AU2005292358B2 (en) 2011-06-16
UA112529C2 (uk) 2016-09-26
EP1807101B1 (en) 2016-04-13
ES2634323T3 (es) 2017-09-27
US9045725B2 (en) 2015-06-02

Similar Documents

Publication Publication Date Title
IL217158A0 (en) Devices and methods for integrated continuous manufacturing of biological molecules
IL188078A0 (en) Nano-ionic liquids and methods of use
IL180251A0 (en) Methods and reagents for the treatment of metabolic disorders
GB0508889D0 (en) Diamond transistor and method of manufacture thereof
IL182734A0 (en) 4-aminotetracyclines and methods of use thereof
ZA200702069B (en) Silver-releasing articles and methods of manufacture
EP1718602A4 (en) THERAPEUTIC AND CARRIER MOLECULES
IL186447A0 (en) Methods for the treatment of substance abuse and dependence
GB2412108B (en) Load-carrying apparatus and methods of manufacture
IL179227A0 (en) Methods and reagents for the treatment of immunoinflammatory disorders
EP1933880A4 (en) OLIGORIBONUCLEOTIDES AND METHODS OF USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES
GB0508101D0 (en) Methods and apparatus for the manufacture of microstructures
IL182436A0 (en) Thienopyridinone compounds and methods of treatment
EP1747494A4 (en) GLASSES AND ASSOCIATED MANUFACTURING METHOD
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
IL178996A0 (en) Thienopyridinone compounds and methods of treatment
GB0421164D0 (en) Medical devices and methods of making medical devices
AP2006003756A0 (en) Anti-parasitic compounds and methods of their use
EP1941920A4 (en) BLOOD FILTER DEVICE AND METHOD FOR THE PRODUCTION THEREOF
EP1815226A4 (en) DEVICE AND METHOD FOR PURIFYING BIOLOGICAL SUBSTANCES
GB0400394D0 (en) Biosensor and method of manufacture
EP1812451A4 (en) COMPOUNDS AND METHODS OF USE THEREOF
ZA200709443B (en) Methods for the treatment of substance abuse and dependence
ZA200700749B (en) Methods and reagents for the treatment of metabolic disorders
ZA200709024B (en) Method of well treatment and construction